Endocrinology News and Research Articles

t:flex Large Capacity Insulin Pump for Diabetes is Available

05/03/2015 - The U.S. Food and Drug Administration approved the t:flex™ insulin pump for marketing. The pump, manufactured by Tandem Diabetes Care, can store the largest amount of insulin (480 units) of any pump available in the United States.

Depression Is Common in Children with Obesity

04/24/2015 - More than one-quarter to one-third of children who have obesity and enter weight management programs, also have depression, according to 2 recent studies.

Depression, Anxiety, and Eating Disorders Are Common in Teens and Young Adults with Type 1 Diabetes

04/21/2015 - Managing type 1 diabetes during the teenage years is challenging. Physical changes, social pressures, and stress can make it harder for teenagers and young adults to control their blood sugar levels.

Hormone Therapy Is Safe in Transgender Adults When Carefully Monitored

04/06/2015 - This review of current studies suggests that transgender hormone therapy is relatively safe for most people. The harms that do exist are relatively rare and can often be avoided with monitoring.

Adult Obesity Treated Using New FDA-approved Device

03/19/2015 - VBLOC vagal blocking therapy delivered via the Maestro System (EnteroMedics Inc., Minneapolis, MN) is now approved to treat adults with obesity. Learn about the device, how it works, side effects, and study results.

Saxenda FDA-approved for Chronic Weight Management

03/19/2015 - Saxenda (liraglutide injection) is now approved for chronic weight management in addition to a reduced-calorie diet and physical activity in adults who are obese or who are overweight and have at least 1 weight-related condition.

Artificial Pancreas Is Being Tested for Overnight Use in Type 1 Diabetes

03/18/2015 - A big challenge for people with type 1 diabetes is managing blood sugar (or glucose) levels when they are asleep. Dips in blood sugar levels overnight may go unrecognized and can lead to serious consequences, including seizures and coma or, in rare cases, death.

Vyvanse® Approved for Binge-Eating Disorder in Adults

02/25/2015 - The U.S. Food and Drug Administration (FDA) recently expanded the approved uses of Vyvanse® (lisdexamfetamine dimesylate) to include treatment of moderate-to-severe binge-eating disorder (BED) in adults.

Diabetes in Middle-Age Linked to Memory and Cognitive Problems 20 Years Later

01/14/2015 - People who develop diabetes or prediabetes in middle-age are more likely to have memory and cognitive problems over the next 20 years compared to people without diabetes in midlife, according to a study in the December 2 Annals of Internal Medicine.